Establishment of MUi030-A: A human induced pluripotent stem cell line carrying homozygous L444P mutation in the GBA1 gene to study type-3 Gaucher disease

Stem Cell Res. 2023 Dec:73:103229. doi: 10.1016/j.scr.2023.103229. Epub 2023 Oct 18.

Abstract

Gaucher disease (GD) is a common lysosomal storage disease resulting from mutations in the glucocerebrosidase (GBA1) gene. This genetic disorder manifests with symptoms affecting multiple organs, yet the underlying mechanisms leading to pathology remain elusive. In this study, we successfully generated the MUi030-A human induced pluripotent stem cell (hiPSC) line using a non-integration method from a male type-3 GD patient with a homozygous c.1448T>C (L444P) mutation. These hiPSCs displayed a normal karyotype and pluripotency markers and the remarkable ability to differentiate into cells representing all three germ layers. This resourceful model holds significant promise for illuminating GD's underlying pathogenesis.

MeSH terms

  • Cells, Cultured
  • Gaucher Disease* / metabolism
  • Glucosylceramidase / genetics
  • Glucosylceramidase / metabolism
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Male
  • Mutation / genetics

Substances

  • Glucosylceramidase